Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-16-156904
Filing Date
2016-11-14
Accepted
2016-11-14 16:25:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a16-20533_1424b5.htm 424B5 150096
2 GRAPHIC g205331cai001.jpg GRAPHIC 2986
3 GRAPHIC g205331hoi001.jpg GRAPHIC 2986
  Complete submission text file 0001104659-16-156904.txt   159580
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214384 | Film No.: 161995100
SIC: 2834 Pharmaceutical Preparations